|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar
|
|
2
|
Brunagel G, Vietmeier BN, Bauer AJ, Schoen
RE and Getzenberg RH: Identification of nuclear matrix protein
alterations associated with human colon cancer. Cancer Res.
62:2437–2442. 2002.PubMed/NCBI
|
|
3
|
Dey P: Chromatin pattern alteration in
malignant cells: an enigma. Diagn Cytopathol. 32:25–30. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zink D, Fischer AH and Nickerson JA:
Nuclear structure in cancer cells. Nat Rev Cancer. 4:677–687. 2004.
View Article : Google Scholar
|
|
5
|
Durfee T, Mancini MA, Jones D, Elledge SJ
and Lee WH: The amino-terminal region of the retinoblastoma gene
product binds a novel nuclear matrix protein that co-localizes to
centers for RNA processing. J Cell Biol. 127:609–622. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nickerson J: Experimental observations of
a nuclear matrix. J Cell Sci. 114:463–474. 2001.PubMed/NCBI
|
|
7
|
Ruh MF, Dunn R 2nd and Ruh TS:
Interrelationships between nuclear structure and ligand-activated
intracellular receptors. Crit Rev Eukaryot Gene Expr. 6:271–283.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Martelli AM, Bareggi R, Bortul R, Grill V,
Narducci P and Zweyer M: The nuclear matrix and apoptosis.
Histochem Cell Biol. 108:1–10. 1997. View Article : Google Scholar
|
|
9
|
Barboro P, Repaci E, D’Arrigo C and Balbi
C: The role of nuclear matrix proteins binding to matrix attachment
regions (Mars) in prostate cancer cell differentiation. PLoS One.
7:e406172012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Getzenberg RH, Konety BR, Oeler TA,
Quigley MM, Hakam A, Becich MJ and Bahnson RR: Bladder
cancer-associated nuclear matrix proteins. Cancer Res.
56:1690–1694. 1996.PubMed/NCBI
|
|
11
|
Konety BR, Nangia AK, Nguyen TS, Veitmeier
BN, Dhir R, Acierno JS, Becich MJ, Hrebinko RL and Getzenberg RH:
Identification of nuclear matrix protein alterations associated
with renal cell carcinoma. J Urol. 159:1359–1363. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Getzenberg RH, Pienta KJ, Huang EY and
Coffey DS: Identification of nuclear matrix proteins in the cancer
and normal rat prostate. Cancer Res. 51:6514–6520. 1991.PubMed/NCBI
|
|
13
|
Luftner D and Possinger K: Nuclear matrix
proteins as biomarkers for breast cancer. Expert Rev Mol Diagn.
2:23–31. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Partin AW, Briggman JV, Subong EN, Szaro
R, Oreper A, Wiesbrock S, Meyer J, Coffey DS and Epstein JI:
Preliminary immunohistochemical characterization of a monoclonal
antibody (PRO:4-216) prepared from human prostate cancer nuclear
matrix proteins. Urology. 50:800–808. 1997. View Article : Google Scholar
|
|
15
|
Guo S, Hakimi MA, Baillat D, Chen X,
Farber MJ, Klein-Szanto AJ, Cooch NS, Godwin AK and Shiekhattar R:
Linking transcriptional elongation and messenger RNA export to
metastatic breast cancers. Cancer Res. 65:3011–3016.
2005.PubMed/NCBI
|
|
16
|
Yang J, Li Y, Khoury T, Alrawi S, Goodrich
DW and Tan D: Relationships of hHpr1/p84/Thoc1 expression to
clinicopathologic characteristics and prognosis in non-small cell
lung cancer. Ann Clin Lab Sci. 38:105–112. 2008.PubMed/NCBI
|
|
17
|
Gasparri F, Sola F, Locatelli G and Muzio
M: The death domain protein p84N5, but not the short isoform
p84N5s, is cell cycle-regulated and shuttles between the nucleus
and the cytoplasm. FEBS Lett. 574:13–19. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Doostzadeh-Cizeron J, Yin S and Goodrich
DW: Apoptosis induced by the nuclear death domain protein p84N5 is
associated with caspase-6 and NF-kappa B activation. J Biol Chem.
275:25336–25341. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Doostzadeh-Cizeron J, Terry NH and
Goodrich DW: The nuclear death domain protein p84N5 activates a
G2/M cell cycle checkpoint prior to the onset of apoptosis. J Biol
Chem. 276:1127–1132. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li Y, Wang X, Zhang X and Goodrich DW:
Human hHpr1/p84/Thoc1 regulates transcriptional elongation and
physically links RNA polymerase II and RNA processing factors. Mol
Cell Biol. 25:4023–4033. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tyagi AK, Singh RP, Agarwal C, Chan DC and
Agarwal R: Silibinin strongly synergizes human prostate carcinoma
DU145 cells to doxorubicin-induced growth inhibition, G2-M arrest,
and apoptosis. Clin Cancer Res. 8:3512–3519. 2002.
|
|
22
|
Singh RP, Dhanalakshmi S and Agarwal R:
Phytochemicals as cell cycle modulators - a less toxic approach in
halting human cancers. Cell Cycle. 1:156–161. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nahta R and Esteva FJ: Bcl-2 antisense
oligonucleotides: a potential novel strategy for the treatment of
breast cancer. Semin Oncol. 30:143–149. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ghobrial IM, Witzig TE and Adjei AA:
Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin.
55:178–194. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kymionis GD, Dimitrakakis CE,
Konstadoulakis MM, Arzimanoglou I, Leandros E, Chalkiadakis G,
Keramopoulos A and Michalas S: Can expression of apoptosis genes,
bcl-2 and bax, predict survival and responsiveness to chemotherapy
in node-negative breast cancer patients? J Surg Res. 99:161–168.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fulda S and Debatin KM: Extrinsic versus
intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene.
25:4798–4811. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Endl E and Gerdes J: The Ki-67 protein:
fascinating forms and an unknown function. Exp Cell Res.
257:231–237. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Scholzen T and Gerdes J: The Ki-67
protein: from the known and the unknown. J Cell Physiol.
182:311–322. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bridger JM, Kill IR and Lichter P:
Association of pKi-67 with satellite DNA of the human genome in
early G1 cells. Chromosome Res. 6:13–24. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
MacCallum DE and Hall PA: The location of
pKi67 in the outer dense fibrillary compartment of the nucleolus
points to a role in ribosome biogenesis during the cell division
cycle. J Pathol. 190:537–544. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ruiz C, Seibt S, Al Kuraya K, Siraj AK,
Mirlacher M, Schraml P, Maurer R, Spichtin H, Torhorst J, Popovska
S, et al: Tissue microarrays for comparing molecular features with
proliferation activity in breast cancer. Int J Cancer.
118:2190–2194. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Irigoyen MA, Garcia FV, Iturriagagoitia
AC, Beroiz BI, Martinez MS and Grima FG: Molecular subtypes of
breast cancer: prognostic implications and clinical and
immunohistochemical characteristics. An Sist Sanit Navar.
34:219–233. 2011.(In Spanish).
|
